Discover how LCC’s highly developable chemical space has been designed to support projects from hit identification, to hit expansion and lead optimisation.
Designed to deliver quality and rapid science to our clients, LCC’s chirally-pure, sp3-rich scaffolds are co-located with our expert chemistry team and parallel synthesis laboratory.
LCC supports orthogonal Hit Identification approaches and technologies:
Founded in 2014, LCC is now established as one of the top chemical technology innovators in the industry.
We believe that curiosity driven by purpose leads to new ideas and faster progress. By offering improved access to 3D chemical space, we help to accelerate the discovery and development of high-quality drugs.
LCC and OpenEye, Cadence Molecular Sciences are proud to announce the launch of a drug-like virtual library of >1 billion compounds that will be available in OpenEye’s cloud-native Orion® molecular design platform.
More Information